消化器科/消化器製品市場 – 2029年までの予測

Report Overview

The global Gastroenterology/Gastrointestinal Products Market is projected to reach USD 19.7 billion by 2029 from USD 14.7 billion in 2024, at a CAGR of  6.1% from 2024 to 2029.

世界の消化器科/消化器製品市場は、2024年から2029年までCAGR 6.1%で、2024年の147億米ドルから2029年までに197億米ドルに達すると予測されています。

The market for gastroenterology and gastrointestinal products is driven by several factors, such as the growing incidence of GI disorders, improvements in technology, aging populations, rising healthcare costs, increased awareness and screening initiatives, rising R&D spending, the need for personalized medicine, and economic expansion in emerging markets. The GI product industry is dynamic and ever-evolving due to the combined influence of these drivers.

“The endoscopy segment from the devices segment  accounted for the largest share during the forecast period.”

The Gastroenterology/Gastrointestinal product market is divided into Endoscopy, Ablations systems, Motility testing, Stenting devices, Ph monitoring, and other devices. The endoscopy segment accounted for the largest share during the forecast period. Endoscopic techniques enable the removal of polyps, tissue biopsies, stent implantation, and tumor ablation, among other therapeutic and diagnostic treatments. These developments support endoscopy’s increasing use for a range of gastrointestinal disorders.

“The GERD segment in the diseases segment accounted for the largest share during the forecast period..”

The increasing prevalence of GERD, driven by lifestyle factors, obesity, aging populations, and enhanced diagnostic and treatment options, is significantly boosting the share of the gastroenterology market. As awareness grows and technological advancements continue, the demand for gastroenterological products and services is expected to rise, further driving market growth. As the global population ages, the incidence of GERD increases. Older adults are more susceptible to GERD due to changes in esophageal motility and the function of the lower esophageal sphincter.

“APAC is estimated to register the highest CAGR during the forecast period.”

The Gastroenterology/Gastrointestinal Products Market is divided into Five regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The Asia Pacific is witnessed to have the highest CAGR during the forecast period.. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. Older persons have a higher prevalence of diseases like GERD and complex healthcare needs.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), Asia Pacific (25%), RoW(16%)

List of Companies Profiled in the Report

          BOSTON SCIENTIFIC (U.S)

          MEDTRONIC (U.S)

          OLYMPUS CORPORATION (JAPAN)

          STRYKER (U.S.)

          GLOBUS MEDICAL (U.S.)

          COOK MEDICAL (US)

          ETHICON (SUBSIDIARY OF J&J)

          FUJIFILM (JAPAN)

          CONMED CORPORATION (US)

          KARL STORZ (GERMANY)

Research Coverage

This report studies the Gastroenterology/Gastrointestinal Products Market based on devices, diseases, end-users and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Gastroenterology/Gastrointestinal Products Market. The report forecasts the revenue of the market segments to five major regions.

Reasons to Buy the Report

This report also includes.

• Analysis of key drivers (increasing GI diseases, technological advancements) , restraints (Cost of the system), challenges(regulatory policies), and opportunities (Increase in the minimally invasive procedures) contributing to the growth of the Gastroenterology/Gastrointestinal Products Market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Gastroenterology/Gastrointestinal Products Market.
• Market Development: Comprehensive information on the lucrative emerging markets by devices, diseases, end-users and region.
• Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Gastroenterology/Gastrointestinal Products Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Gastroenterology/Gastrointestinal Products Market..

Table of Contents

1            INTRODUCTION            33

1.1         STUDY OBJECTIVES      33

1.2         MARKET DEFINITION   33

1.2.1      INCLUSIONS & EXCLUSIONS     33

1.3         MARKET SCOPE             34

1.3.1      MARKETS COVERED     34

1.3.2      YEARS CONSIDERED     35

1.3.3      CURRENCY CONSIDERED          35

1.4         STAKEHOLDERS            36

1.5         SUMMARY OF CHANGES            37

2            RESEARCH METHODOLOGY     38

2.1         RESEARCH DATA           38

2.1.1      SECONDARY DATA       39

2.1.1.1   Key data from secondary sources     41

2.1.2      PRIMARY DATA 41

2.1.2.1   Key data from primary sources         43

2.1.2.2   Key industry insights          44

2.2         MARKET SIZE ESTIMATION       45

2.3         MARKET BREAKDOWN & DATA TRIANGULATION          49

2.4         MARKET RANKING ANALYSIS   50

2.5         STUDY ASSUMPTIONS  51

2.6         RISK ASSESSMENT         51

2.7         LIMITATIONS   51

2.7.1      METHODOLOGY-RELATED LIMITATIONS         51

3            EXECUTIVE SUMMARY 52

4            PREMIUM INSIGHTS      56

4.1         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET OVERVIEW        56

4.2         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE AND REGION (2023) 57

4.3         GEOGRAPHIC SNAPSHOT OF GASTROENTEROLOGY/GASTROINTESTINAL

PRODUCTS MARKET     58

5            MARKET OVERVIEW     59

5.1         INTRODUCTION            59

5.2         MARKET DYNAMICS     59

5.2.1      DRIVERS            60

5.2.1.1   Rising prevalence of GI disorders     60

5.2.1.2   Technological advancements in gastroenterology products        60

5.2.1.3   Growing aging population 61

5.2.2      RESTRAINTS     62

5.2.2.1   Stringent regulatory policies for GI products  62

5.2.2.2   Increasing healthcare costs 62

5.2.2.3   Unfavorable healthcare reforms in US            64

5.2.3      OPPORTUNITIES           64

5.2.3.1   Increasing preference for minimally invasive surgery   64

5.2.4      CHALLENGES   65

5.2.4.1   Changing regulatory landscape        65

5.2.4.2   Shortage of trained physicians and endoscopists          65

5.3         INDUSTRY TRENDS       66

5.4         TECHNOLOGY ANALYSIS           66

5.4.1      KEY TECHNOLOGIES    66

5.4.1.1   Capsule endoscopy            66

5.4.2      COMPLEMENTARY TECHNOLOGIES     67

5.4.2.1   Laboratory testing             67

5.4.3      ADJACENT TECHNOLOGIES      67

5.4.3.1   Robotic surgery systems     67

5.5         VALUE CHAIN ANALYSIS            68

5.6         PORTER’S FIVE FORCE ANALYSIS           69

5.6.1      THREAT OF NEW ENTRANTS    70

5.6.2      THREAT OF SUBSTITUTES         70

5.6.3      BARGAINING POWER OF SUPPLIERS     70

5.6.4      BARGAINING POWER OF BUYERS           70

5.6.5      INTENSITY OF COMPETITIVE RIVALRY 70

5.7         REGULATORY LANDSCAPE       71

5.7.1      REGULATORY ANALYSIS            71

5.7.1.1   North America     71

5.7.1.1.1 US         71

5.7.1.1.2 Canada  72

5.7.1.2   Europe  72

5.7.1.3   Asia Pacific          72

5.7.1.3.1 Japan     72

5.7.1.3.2 China     73

5.7.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          74

5.8         PATENT ANALYSIS        76

5.8.1      PATENT PUBLICATION TRENDS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS          76

5.8.2      INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS        77

5.9         TRADE ANALYSIS          78

5.9.1      HS CODES: GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS 78

5.9.2      IMPORT DATA 79

5.9.3      EXPORT DATA 79

5.10       PRICING ANALYSIS        80

5.11       REIMBURSEMENT ANALYSIS     81

5.12       KEY CONFERENCES & EVENTS, 2024–2025           83

5.13       KEY STAKEHOLDERS & BUYING CRITERIA          84

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         84

5.13.2    BUYING CRITERIA         85

5.14       UNMET NEEDS ANALYSIS          86

5.15       END-USER EXPECTATIONS       87

5.16       ECOSYSTEM ANALYSIS 88

5.17       CASE STUDY ANALYSIS 89

5.18       SUPPLY CHAIN ANALYSIS          89

5.19       INVESTMENT & FUNDING SCENARIO    91

5.20       IMPACT OF GEN AI/AI ON GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET        91

6            GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE 94

6.1         INTRODUCTION            95

6.2         ENDOSCOPY DEVICES  96

6.2.1      FLEXIBLE ENDOSCOPES            98

6.2.1.1   Advantages such as flexibility and ease of use to drive demand for flexible endoscopes          98

6.2.2      RIGID ENDOSCOPES     99

6.2.2.1   Ability of rigid endoscopes to provide vertical-axis images of internal organs to support market growth       99

6.2.3      CAPSULE ENDOSCOPES             100

6.2.3.1   Non-invasive nature of capsule endoscopes to drive adoption    100

6.2.4      OTHER ENDOSCOPY DEVICES  102

6.3         ABLATION DEVICES      103

6.3.1      RADIOFREQUENCY ABLATION DEVICES            104

6.3.1.1   Low cost of radiofrequency ablation to contribute to market growth         104

6.3.2      MICROWAVE ABLATION DEVICES         106

6.3.2.1   Advantages over RF ablation to ensure sustained demand for microwave ablation devices   106

6.3.3      CRYOABLATION DEVICES         107

6.3.3.1   Increasing cancer incidence to drive market for cryoablation devices       107

6.3.4      LASER ABLATION DEVICES       108

6.3.4.1   High efficacy and safety to drive adoption of laser/light ablation devices  108

6.3.5      OTHER ABLATION DEVICES      110

6.4         MOTILITY TESTING DEVICES   111

6.4.1      ESOPHAGEAL MANOMETRY DEVICES   112

6.4.1.1   Rising incidence of esophageal motility disorders to boost market growth 112

6.4.2      4-HOUR PH IMPEDANCE TESTING DEVICES      114

6.4.2.1   Ability to provide data useful for tailoring individualized treatment plans to favor market growth     114

6.4.3      ANORECTAL MANOMETRY DEVICES     115

6.4.3.1   Growing popularity of anorectal manometry devices for diagnosis of gastrointestinal problems to support market growth     115

6.4.4      OTHER MOTILITY TESTING DEVICES   116

6.5         BIOPSY DEVICES            117

6.5.1      NEEDLE BIOPSY DEVICES          119

6.5.1.1   Increasing screening of gastrointestinal diseases to aid growth   119

6.5.2      OTHER BIOPSY DEVICES            120

6.6         STENTING DEVICES      121

6.6.1      BILIARY STENTS            123

6.6.1.1   Increasing prevalence of bile duct cancer and chronic liver disease to drive growth              123

6.6.2      COLONIC STENTS         126

6.6.2.1   Rising demand for colonic stents due to high incidence of colorectal cancer to drive segmental growth 126

6.6.3      DUODENAL STENTS     127

6.6.3.1   Increasing prevalence of intestinal malignancy to boost adoption of duodenal stents     127

6.6.4      PANCREATIC STENTS   130

6.6.4.1   Rising number of ERCP and PTC procedures to drive market growth      130

6.6.5      ESOPHAGEAL STENTS  132

6.6.5.1   Increasing incidence of esophageal cancer to propel market growth         132

6.7         PH MONITORING DEVICES        133

6.7.1      ESOPHAGEAL PH MONITORING CATHETERS    135

6.7.1.1   Growing sedentary lifestyles to drive demand 135

6.7.2      WIRELESS PH MONITORING CAPSULES 136

6.7.2.1   Reduced risk of open surgeries to boost market            136

6.7.3      AMBULATORY PH MONITORING SYSTEMS        137

6.7.3.1   Convenience and accuracy of ambulatory pH monitoring to drive market 137

6.8         OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES 139

6.8.1      GASTRIC BALLOONS    140

6.8.1.1   Minimally invasive nature of gastric balloons to boost adoption 140

6.8.2      GASTROINTESTINAL TUBES     141

6.8.2.1   Rising incidence of diseases to drive need for gastrointestinal tubes         141

6.8.3      HEMORRHOID TREATMENT DEVICES  143

6.8.3.1   Rising cases of hemorrhoids to support market growth 143

7            GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE            144

7.1         INTRODUCTION            145

7.2         GASTROINTESTINAL CANCERS 146

7.2.1      CHANGING DIETS AND GROWING PREVALENCE OF OBESITY TO BOOST MARKET GROWTH        146

7.3         GASTROESOPHAGEAL REFLUX DISEASE             147

7.3.1      GROWING INCIDENCE OF GERD TO DRIVE MARKET GROWTH 147

7.4         IRRITABLE BOWEL SYNDROME (IBS)     149

7.4.1      GROWING IBS DISEASE BURDEN TO DRIVE DEMAND FOR GASTROINTESTINAL PRODUCTS           149

7.5         INFLAMMATORY BOWEL DISEASE (IBD)             150

7.5.1      GROWING USE OF CAPSULE ENDOSCOPES IN TREATING IBD TO FAVOR MARKET GROWTH        150

7.6         OTHER DISEASES          152

8            GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER    154

8.1         INTRODUCTION            155

8.2         HOSPITALS       155

8.2.1      HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL PROCEDURES IN HOSPITALS          155

8.3         AMBULATORY SURGICAL CENTERS & INDEPENDENT SURGICAL CENTERS           157

8.3.1      LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE MARKET GROWTH          157

8.4         CLINICS             158

8.4.1      GROWING NEED FOR CLINICAL SCREENING TO DIAGNOSE GASTROINTESTINAL DISEASES TO BOOST MARKET      158

8.5         OTHER END USERS        160

9            GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION             161

9.1         INTRODUCTION            162

9.2         NORTH AMERICA          162

9.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA   164

9.2.2      US         168

9.2.2.1   US to dominate North American market during forecast period 168

9.2.3      CANADA            174

9.2.3.1   Increased availability of funding and presence of research institutes to propel market   174

9.3         EUROPE             179

9.3.1      MACROECONOMIC OUTLOOK FOR EUROPE     180

9.3.2      GERMANY         184

9.3.2.1   Favorable reimbursement scenario and increased geriatric population to aid market growth     184

9.3.3      UK         190

9.3.3.1   Rising investments by hospitals in new and advanced gastroenterology/gastrointestinal products to augment market growth     190

9.3.4      FRANCE             195

9.3.4.1   Increase in health expenditure and high prevalence of cancer to stimulate market growth   195

9.3.5      ITALY   200

9.3.5.1   High per capita income and improved healthcare system to drive market 200

9.3.6      SPAIN   205

9.3.6.1   Growing prevalence of cardiovascular diseases to boost market growth    205

9.3.7      REST OF EUROPE           210

9.4         ASIA PACIFIC    215

9.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC          217

9.4.2      JAPAN  222

9.4.2.1   Favorable medical device reimbursement policies and public health insurance schemes to aid market growth          222

9.4.3      CHINA  227

9.4.3.1   Increasing geriatric population and increase in domestic manufacturers for gastrointestinal products to support growth   227

9.4.4      INDIA   232

9.4.4.1   Increasing incidence of diseases like diabetes to enhance market growth  232

9.4.5      AUSTRALIA       236

9.4.5.1   High incidence of cancer to propel market growth       236

9.4.6      SOUTH KOREA 242

9.4.6.1   Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth     242

9.4.7      REST OF ASIA PACIFIC  247

9.5         LATIN AMERICA             252

9.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA     253

9.5.2      BRAZIL 257

9.5.2.1   Increase in private healthcare investments and rise in medical tourism to aid market growth     257

9.5.3      MEXICO             263

9.5.3.1   Increased government investment in healthcare infrastructure and technological advancements to aid market growth 263

9.5.4      REST OF LATIN AMERICA          268

9.6         MIDDLE EAST & AFRICA             272

9.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA     272

9.6.2      GCC COUNTRIES           277

9.6.2.1   Increasing investment in healthcare infrastructure and growing medical tourism to propel market growth     277

9.6.3      REST OF MIDDLE EAST & AFRICA           281

10          COMPETITIVE LANDSCAPE       286

10.1       OVERVIEW        286

10.2       KEY PLAYER STRATEGY/RIGHT TO WIN             286

10.3       REVENUE ANALYSIS, 2021–2023 287

10.4       MARKET SHARE ANALYSIS, 2023             288

10.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   290

10.5.1    STARS  291

10.5.2    EMERGING LEADERS    291

10.5.3    PERVASIVE PLAYERS     291

10.5.4    PARTICIPANTS 291

10.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      293

10.5.5.1 Company footprint            293

10.5.5.2 Disease footprint 294

10.5.5.3 End-user footprint             295

10.5.5.4 Region footprint  296

10.6       COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023         296

10.6.1    PROGRESSIVE COMPANIES       296

10.6.2    RESPONSIVE COMPANIES          296

10.6.3    DYNAMIC COMPANIES 297

10.6.4    STARTING BLOCKS       297

10.6.5    COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023           298

10.7       COMPETITIVE SCENARIO          299

10.7.1    PRODUCT LAUNCHES & APPROVALS    299

10.7.2    DEALS  301

10.7.3    EXPANSIONS    303

10.8       BRAND/PRODUCT COMPARISON          304

10.9       COMPANY VALUATION & FINANCIAL METRICS 304

10.9.1    FINANCIAL METRICS    304

10.9.2    COMPANY VALUATION 305

11          COMPANY PROFILES    306

11.1       KEY PLAYERS   306

11.1.1    OLYMPUS CORPORATION         306

11.1.1.1 Business overview 306

11.1.1.2 Products offered  307

11.1.1.3 Recent developments         309

11.1.1.3.1            Product launches & approvals          309

11.1.1.3.2            Deals     310

11.1.1.3.3            Expansions          311

11.1.1.4 MnM view           313

11.1.1.4.1            Right to win         313

11.1.1.4.2            Strategic choices  313

11.1.1.4.3            Weaknesses & competitive threats   313

11.1.2    BOSTON SCIENTIFIC CORPORATION    314

11.1.2.1 Business overview 314

11.1.2.2 Products offered  315

11.1.2.3 Recent developments         317

11.1.2.3.1            Product launches & approvals          317

11.1.2.3.2            Deals     318

11.1.2.4 MnM view           318

11.1.2.4.1            Right to win         318

11.1.2.4.2            Strategic choices  319

11.1.2.4.3            Weaknesses & competitive threats   319

11.1.3    MEDTRONIC PLC           320

11.1.3.1 Business overview 320

11.1.3.2 Products offered  321

11.1.3.3 Recent developments         323

11.1.3.3.1            Product approvals 323

11.1.3.3.2            Deals     324

11.1.3.4 MnM view           324

11.1.3.4.1            Right to win         324

11.1.3.4.2            Strategic choices  324

11.1.3.4.3            Weaknesses & competitive threats   324

11.1.4    STRYKER CORPORATION           325

11.1.4.1 Business overview 325

11.1.4.2 Products offered  326

11.1.4.3 Recent developments         327

11.1.4.3.1            Product approvals 327

11.1.4.3.2            Deals     327

11.1.4.3.3            Expansions          328

11.1.4.4 MnM view           328

11.1.4.4.1            Right to win         328

11.1.4.4.2            Strategic choices  328

11.1.4.4.3            Weaknesses & competitive threats   328

11.1.5    COOK MEDICAL            329

11.1.5.1 Business overview 329

11.1.5.2 Products offered  330

11.1.5.3 Recent developments         331

11.1.5.3.1            Product launches & approvals          331

11.1.5.3.2            Deals     332

11.1.5.4 MnM view           333

11.1.5.4.1            Right to win         333

11.1.5.4.2            Strategic choices  333

11.1.5.4.3            Weaknesses & competitive threats   333

11.1.6    FUJIFILM CORPORATION           334

11.1.6.1 Business overview 334

11.1.6.2 Products offered  336

11.1.6.3 Recent developments         337

11.1.6.3.1            Product launches & approvals          337

11.1.6.3.2            Other developments          338

11.1.7    CONMED CORPORATION          339

11.1.7.1 Business overview 339

11.1.7.2 Products offered  341

11.1.8    ETHICON (A JOHNSON & JOHNSON SUBSIDIARY)           342

11.1.8.1 Business overview 342

11.1.8.2 Products offered  343

11.1.8.3 Recent developments         344

11.1.8.3.1            Product launches & approvals          344

11.1.9    MERIT MEDICAL SYSTEMS        345

11.1.9.1 Business overview 345

11.1.9.2 Products offered  347

11.1.9.3 Recent developments         348

11.1.9.3.1            Product launches 348

11.1.10  STERIS PLC       349

11.1.10.1             Business overview 349

11.1.10.2             Products offered  350

11.1.11  KARL STORZ SE & CO. KG           352

11.1.11.1             Business overview 352

11.1.11.2             Products offered  353

11.1.11.3             Recent developments         354

11.1.11.3.1          Deals     354

11.2       OTHER PLAYERS           355

11.2.1    SHAILI ENDOSCOPY     355

11.2.2    TAEWOONG MEDICAL CO., LTD.           356

11.2.3    HOBBS MEDICAL, INC.  357

11.2.4    PENTAX MEDICAL         358

11.2.5    ERBE ELEKTROMEDIZIN            359

11.2.6    AMBU A/S          360

11.2.7    CAPSOVISION, INC.       361

11.2.8    INTROMEDIC, INC.        361

11.2.9    VIMEX ENDOSCOPY      362

11.2.10  TRIVITRON HEALTHCARE         362

11.2.11  MEDI-GLOBE CORPORATION   363

11.2.12  SONOSCAPE MEDICAL CORP.   363

11.2.13  SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.   364

11.2.14  MEDSPIRA         364

12          APPENDIX         365

12.1       DISCUSSION GUIDE      365

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             371

12.3       CUSTOMIZATION OPTIONS      373

12.4       RELATED REPORTS       373

12.5       AUTHOR DETAILS         374

LIST OF TABLES

TABLE 1             STANDARD CURRENCY CONVERSION RATES    35

TABLE 2             GLOBAL HEALTHCARE EXPENDITURES, BY REGION, 2022–2023              62

TABLE 3             ASIA PACIFIC: HEALTHCARE EXPENDITURE, BY COUNTRY, 2022–2023          63

TABLE 4             GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

PORTER’S FIVE FORCES ANALYSIS         69

TABLE 5             NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 74

TABLE 6             EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 74

TABLE 7             ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 75

TABLE 8             LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 75

TABLE 9             MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 76

TABLE 10           HS CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS 78

TABLE 11           IMPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND)        79

TABLE 12           EXPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND)        79

TABLE 13           AVERAGE SELLING PRICE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS, BY KEY PLAYER, 2023 (USD)        80

TABLE 14          AVERAGE SELLING PRICE OF GASTROINTESTINAL PRODUCTS, BY REGION,

2021–2023          81

TABLE 15           REIMBURSEMENT CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL PROCEDURES      82

TABLE 16           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

KEY CONFERENCES & EVENTS, 2024–2025           83

TABLE 17           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS          84

TABLE 18           KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS          85

TABLE 19           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: UNMET NEEDS           86

TABLE 20           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: END-USER EXPECTATIONS    87

TABLE 21           CASE STUDY 1: AI-ENHANCED CAPSULE ENDOSCOPY FOR SMALL BOWEL

DISEASE DETECTION   89

TABLE 22           CASE STUDY 2: RADIOFREQUENCY ABLATION FOR BARRETT’S ESOPHAGUS     89

TABLE 23           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: AI INTEGRATION       92

TABLE 24           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)             95

TABLE 25           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              96

TABLE 26           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS)              96

TABLE 27           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)              97

TABLE 28           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)          99

TABLE 29           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)              100

TABLE 30           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CAPSULE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)          101

TABLE 31           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)          102

TABLE 32           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 103

TABLE 33           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, VOLUME DATA 2022–2029 (THOUSAND UNITS)     103

TABLE 34           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)              104

TABLE 35           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)     105

TABLE 36           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MICROWAVE ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)          106

TABLE 37           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CRYOABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)          108

TABLE 38           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR LASER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)          109

TABLE 39           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)          110

TABLE 40           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          111

TABLE 41           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)          112

TABLE 42           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 113

TABLE 43           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR 4-HOUR PH IMPEDANCE TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)     115

TABLE 44           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ANORECTAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 116

TABLE 45           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 117

TABLE 46           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)      118

TABLE 47           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)              118

TABLE 48           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR NEEDLE BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)              120

TABLE 49           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR OTHER BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 121

TABLE 50           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)   122

TABLE 51           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS)        122

TABLE 52           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)        123

TABLE 53           BILIARY STENTS OFFERED BY PROMINENT PLAYERS    124

TABLE 54           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BILIARY STENTS, BY COUNTRY, 2022–2029 (USD MILLION)              125

TABLE 55           COLONIC STENTS OFFERED BY PROMINENT PLAYERS 126

TABLE 56           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR COLONIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION)              127

TABLE 57           DUODENAL STENTS OFFERED BY PROMINENT PLAYERS              128

TABLE 58           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR DUODENAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION)              129

TABLE 59           PANCREATIC STENTS OFFERED BY PROMINENT PLAYERS              130

TABLE 60           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PANCREATIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION)              131

TABLE 61           ESOPHAGEAL STENTS OFFERED BY PROMINENT PLAYERS              132

TABLE 62           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION)              133

TABLE 63           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)              134

TABLE 64           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)          134

TABLE 65           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL PH MONITORING CATHETERS, BY COUNTRY, 2022–2029 (USD MILLION)          135

TABLE 66           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR WIRELESS PH MONITORING CAPSULES, BY COUNTRY, 2022–2029 (USD MILLION) 137

TABLE 67           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY PH MONITORING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     138

TABLE 68           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          139

TABLE 69           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY COUNTRY,

2022–2029 (USD MILLION)          140

TABLE 70           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTRIC BALLOONS, BY COUNTRY, 2022–2029 (USD MILLION)              141

TABLE 71           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL TUBES, BY COUNTRY, 2022–2029 (USD MILLION)          142

TABLE 72           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HEMORRHOID TREATMENT DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 143

TABLE 73           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 145

TABLE 74           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL CANCERS, BY COUNTRY, 2022–2029 (USD MILLION)          147

TABLE 75           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD), BY COUNTRY,

2022–2029 (USD MILLION)          148

TABLE 76           TYPES OF IBS WITH SEVERITY INDEX    149

TABLE 77           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR IRRITABLE BOWEL SYNDROME (IBS), BY COUNTRY, 2022–2029 (USD MILLION) 150

TABLE 78           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR INFLAMMATORY BOWEL DISEASE (IBD), BY COUNTRY, 2022–2029 (USD MILLION)     151

TABLE 79           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)              153

TABLE 80           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            155

TABLE 81           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)       156

TABLE 82           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS, BY COUNTRY,

2022–2029 (USD MILLION)          158

TABLE 83           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            159

TABLE 84           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    160

TABLE 85           GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)            162

TABLE 86           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    164

TABLE 87           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)          164

TABLE 88           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)       165

TABLE 89           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)           165

TABLE 90           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)         166

TABLE 91           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)   166

TABLE 92           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)           166

TABLE 93           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     167

TABLE 94           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)     167

TABLE 95           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)       167

TABLE 96           NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)             168

TABLE 97           MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024          169

TABLE 98           LIST OF DEVICES THAT RECEIVED FDA APPROVALS BETWEEN 2020 AND 2023  169

TABLE 99           US: MACROECONOMIC INDICATORS    170

TABLE 100         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)             170

TABLE 101         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              171

TABLE 102         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 171

TABLE 103         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          171

TABLE 104         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)      172

TABLE 105         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 172

TABLE 106         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)              172

TABLE 107         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          173

TABLE 108         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 173

TABLE 109         US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            174

TABLE 110         CANADA: MACROECONOMIC INDICATORS       175

TABLE 111         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   175

TABLE 112         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          176

TABLE 113         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          176

TABLE 114         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 177

TABLE 115         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              177

TABLE 116         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          177

TABLE 117         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)             178

TABLE 118         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          178

TABLE 119         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 179

TABLE 120         CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            179

TABLE 121         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   180

TABLE 122         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          180

TABLE 123         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          181

TABLE 124         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 181

TABLE 125         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              181

TABLE 126         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          182

TABLE 127         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)             182

TABLE 128         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          183

TABLE 129         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 183

TABLE 130         EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            184

TABLE 131         GERMANY: MACROECONOMIC INDICATORS     185

TABLE 132         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION) 185

TABLE 133         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)             186

TABLE 134         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 186

TABLE 135         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 187

TABLE 136         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)         187

TABLE 137         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)   187

TABLE 138         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     188

TABLE 139         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          188

TABLE 140         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 189

TABLE 141         GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            189

TABLE 142         UK: MACROECONOMIC INDICATORS    190

TABLE 143         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)             191

TABLE 144         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              191

TABLE 145         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 192

TABLE 146         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          192

TABLE 147         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)      192

TABLE 148         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)   193

TABLE 149         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     193

TABLE 150         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          194

TABLE 151         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 194

TABLE 152         UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            195

TABLE 153         FRANCE: MACROECONOMIC INDICATORS        196

TABLE 154         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   196

TABLE 155         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)             196

TABLE 156         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)   197

TABLE 157         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 197

TABLE 158         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)         198

TABLE 159         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)   198

TABLE 160         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     198

TABLE 161         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          199

TABLE 162         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 199

TABLE 163         FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            200

TABLE 164         ITALY: MACROECONOMIC INDICATORS            201

TABLE 165         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)      201

TABLE 166         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)             202

TABLE 167         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)   202

TABLE 168         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 203

TABLE 169         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)         203

TABLE 170         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)   203

TABLE 171         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          204

TABLE 172         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          204

TABLE 173         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 205

TABLE 174         ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            205

TABLE 175         SPAIN: MACROECONOMIC INDICATORS            206

TABLE 176         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   206

TABLE 177         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          207

TABLE 178         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          207

TABLE 179         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 208

TABLE 180         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              208

TABLE 181         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          208

TABLE 182         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     209

TABLE 183         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          209

TABLE 184         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 210

TABLE 185         SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            210

TABLE 186         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)          211

TABLE 187         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)       212

TABLE 188         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)           212

TABLE 189         REST OF EUROPE: : GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)         213

TABLE 190         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)   213

TABLE 191         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)           213

TABLE 192         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     214

TABLE 193         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)     214

TABLE 194         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)       215

TABLE 195         REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)             215

TABLE 196         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            217

TABLE 197         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   217

TABLE 198         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)           218

TABLE 199         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)   218

TABLE 200         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 219

TABLE 201         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)         219

TABLE 202         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          219

TABLE 203         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     220

TABLE 204         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          220

TABLE 205         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 221

TABLE 206         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            221

TABLE 207         JAPAN: MACROECONOMIC INDICATORS            222

TABLE 208         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   223

TABLE 209         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)             223

TABLE 210         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION) 224

TABLE 211         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 224

TABLE 212         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)         224

TABLE 213         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)   225

TABLE 214         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)             225

TABLE 215         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          225

TABLE 216         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 226

TABLE 217         JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            226

TABLE 218         CHINA: MACROECONOMIC INDICATORS           227

TABLE 219         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   228

TABLE 220         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          228

TABLE 221         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          229

TABLE 222         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 229

TABLE 223         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              229

TABLE 224         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          230

TABLE 225         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     230

TABLE 226         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          231

TABLE 227         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 231

TABLE 228         CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            232

TABLE 229         INDIA: MACROECONOMIC INDICATORS            233

TABLE 230         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)      233

TABLE 231         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          233

TABLE 232         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          234

TABLE 233         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 234

TABLE 234         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              234

TABLE 235         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          235

TABLE 236         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          235

TABLE 237         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          235

TABLE 238         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 236

TABLE 239         INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            236

TABLE 240         AUSTRALIA: MACROECONOMIC INDICATORS  237

TABLE 241         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   237

TABLE 242         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          238

TABLE 243         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          238

TABLE 244         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 239

TABLE 245         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              239

TABLE 246         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          239

TABLE 247         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          240

TABLE 248         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          240

TABLE 249         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 241

TABLE 250         AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            241

TABLE 251         SOUTH KOREA: MACROECONOMIC INDICATORS          242

TABLE 252         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)      243

TABLE 253         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          243

TABLE 254         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          244

TABLE 255         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 244

TABLE 256         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              245

TABLE 257         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          245

TABLE 258         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          245

TABLE 259         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          246

TABLE 260         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)     246

TABLE 261         SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 247

TABLE 262         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)          248

TABLE 263         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)       248

TABLE 264         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)           249

TABLE 265         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)         249

TABLE 266         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)   249

TABLE 267         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)           250

TABLE 268         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)     250

TABLE 269         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)     251

TABLE 270         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)       251

TABLE 271         REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)             252

TABLE 272         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)      253

TABLE 273         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          254

TABLE 274         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          254

TABLE 275         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 255

TABLE 276         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              255

TABLE 277         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          255

TABLE 278         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          256

TABLE 279         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          256

TABLE 280         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)     257

TABLE 281         LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 257

TABLE 282         BRAZIL: MACROECONOMIC INDICATORS          258

TABLE 283         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   258

TABLE 284         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)          259

TABLE 285         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)          259

TABLE 286         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 260

TABLE 287         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)              260

TABLE 288         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          261

TABLE 289         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)          261

TABLE 290         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          262

TABLE 291         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 262

TABLE 292         BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)            263

TABLE 293         MEXICO: MACROECONOMIC INDICATORS        263

TABLE 294         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2022–2029 (USD MILLION)   264

TABLE 295         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)             264

TABLE 296         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)   265

TABLE 297         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION) 265

TABLE 298         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)       265

TABLE 299         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)   266

TABLE 300         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          266

TABLE 301         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2022–2029 (USD MILLION) 267

TABLE 302         MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 267

TABLE 303         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)          268

TABLE 304         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)       268

TABLE 305         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)           269

TABLE 306         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)         269

TABLE 307         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)   269

TABLE 308         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)           270

TABLE 309         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES,

BY TYPE, 2022–2029 (USD MILLION)       270

TABLE 310         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)       271

TABLE 311         REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)             271

TABLE 312         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)       272

TABLE 313         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)          273

TABLE 314         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)       273

TABLE 315         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)           274

TABLE 316         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)         274

TABLE 317         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)   274

TABLE 318         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)           275

TABLE 319         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)     275

TABLE 320         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)       276

TABLE 321         MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)             276

TABLE 322         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)          277

TABLE 323         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)       278

TABLE 324         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)           278

TABLE 325         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)         279

TABLE 326         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)   279

TABLE 327         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)           279

TABLE 328         GCC COUNTRIES GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE,

2022–2029 (USD MILLION)          280

TABLE 329         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,

2022–2029 (USD MILLION)          280

TABLE 330         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)       281

TABLE 331         GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)             281

TABLE 332         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)          282

TABLE 333         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE,

2022–2029 (USD MILLION)          282

TABLE 334         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE,

2022–2029 (USD MILLION)          283

TABLE 335         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE,

2022–2029 (USD MILLION)          283

TABLE 336         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)   283

TABLE 337         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE,

2022–2029 (USD MILLION)          284

TABLE 338         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE,

2022–2029 (USD MILLION)          284

TABLE 339         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)     284

TABLE 340         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)       285

TABLE 341         REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)             285

TABLE 342         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

DEGREE OF COMPETITION     289

TABLE 343         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

DEVICE FOOTPRINT     294

TABLE 344         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

DISEASE FOOTPRINT    294

TABLE 345         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

END-USER FOOTPRINT 295

TABLE 346         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

REGION FOOTPRINT    296

TABLE 347         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

KEY START-UPS/SMES  298

TABLE 348         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

PRODUCT LAUNCHES & APPROVALS, MAY 2020–MARCH 2024   299

TABLE 349         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DEALS, JANUARY 2020–FEBRUARY 2024            301

TABLE 350         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

EXPANSIONS, JANUARY 2020–FEBRUARY 2024    303

TABLE 351         OLYMPUS CORPORATION: COMPANY OVERVIEW          306

TABLE 352         OLYMPUS CORPORATION: PRODUCTS OFFERED           307

TABLE 353         OLYMPUS CORPORATION: PRODUCTS LAUNCHES & APPROVALS,

JANUARY 2020–AUGUST 2024     309

TABLE 354         OLYMPUS CORPORATION: DEALS, JANUARY 2020–AUGUST 2024      310

TABLE 355         OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2020–AUGUST 2024    311

TABLE 356         BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW              314

TABLE 357         BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED              315

TABLE 358         BOSTON SCIENTIFIC CORPORATION: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2020– AUGUST 2024     317

TABLE 359         BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2020–AUGUST 2024    318

TABLE 360         MEDTRONIC PLC: COMPANY OVERVIEW           320

TABLE 361         MEDTRONIC PLC: PRODUCTS OFFERED            321

TABLE 362         MEDTRONIC PLC: PRODUCTS APPROVALS, JANUARY 2020–AUGUST 2024    323

TABLE 363         MEDTRONIC PLC: DEALS, JANUARY 2020–AUGUST 2024 324

TABLE 364         STRYKER CORPORATION: COMPANY OVERVIEW           325

TABLE 365         STRYKER CORPORATION: PRODUCTS OFFERED            326

TABLE 366         STRYKER CORPORATION: PRODUCT APPROVALS, JANUARY 2020–AUGUST 2024        327

TABLE 367         STRYKER CORPORATION: DEALS, JANUARY 2020–AUGUST 2024              327

TABLE 368         STRYKER CORPORATION: EXPANSIONS, JANUARY 2020–AUGUST 2024    328

TABLE 369         COOK MEDICAL: COMPANY OVERVIEW             329

TABLE 370         COOK MEDICAL: PRODUCTS OFFERED 330

TABLE 371         COOK MEDICAL: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2020–AUGUST 2024     331

TABLE 372         COOK MEDICAL: DEALS, JANUARY 2020–AUGUST 2024  332

TABLE 373         FUJIFILM CORPORATION: COMPANY OVERVIEW           334

TABLE 374         FUJIFILM CORPORATION: PRODUCTS OFFERED            336

TABLE 375         FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2020–AUGUST 2024     337

TABLE 376         FUJIFILM CORPORATION: OTHER DEVELOPMENTS, JANUARY 2020–AUGUST 2024        338

TABLE 377         CONMED CORPORATION: COMPANY OVERVIEW           339

TABLE 378         CONMED CORPORATION: PRODUCTS OFFERED            341

TABLE 379         ETHICON: COMPANY OVERVIEW           342

TABLE 380         ETHICON: PRODUCTS OFFERED            343

TABLE 381         ETHICON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2024        344

TABLE 382         MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW         345

TABLE 383         MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED          347

TABLE 384         MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES, JANUARY 2020–AUGUST 2024        348

TABLE 385         STERIS PLC: COMPANY OVERVIEW        349

TABLE 386         STERIS PLC: PRODUCTS OFFERED         350

TABLE 387         KARL STORZ SE & CO. KG: COMPANY OVERVIEW           352

TABLE 388         KARL STORZ SE & CO. KG: PRODUCTS OFFERED            353

TABLE 389         KARL STORZ SE & CO. KG: DEALS, JANUARY 2020–AUGUST 2024              354

LIST OF FIGURES

FIGURE 1           RESEARCH DESIGN       38

FIGURE 2           PRIMARY SOURCES       42

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION    44

FIGURE 4           MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 45

FIGURE 5           TOP-DOWN APPROACH             46

FIGURE 6           MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT              47

FIGURE 7           DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029): IMPACT LEVEL OF CAGR    48

FIGURE 8           CAGR PROJECTIONS     48

FIGURE 9           DATA TRIANGULATION METHODOLOGY         50

FIGURE 10         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DEVICE, 2024 VS. 2029 (USD MILLION)           52

FIGURE 11         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY DISEASE, 2024 VS. 2029 (USD MILLION)          53

FIGURE 12         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,

BY END USER, 2024 VS. 2029 (USD MILLION)       53

FIGURE 13         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR

ENDOSCOPY DEVICES, BY TYPE, 2024 VS. 2029 (USD MILLION)  54

FIGURE 14         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

GEOGRAPHIC SNAPSHOT          55

FIGURE 15         INCREASING PREVALENCE OF GI DISORDERS TO DRIVE MARKET GROWTH        56

FIGURE 16         ENDOSCOPY DEVICES ACCOUNTED FOR LARGEST SHARE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET IN 2023              57

FIGURE 17         CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD              58

FIGURE 18         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59

FIGURE 19         ADVANCEMENTS IN TECHNOLOGY, FOCUS ON PREVENTIVE CARE,

AND SHIFT TOWARD PATIENT-CENTERED APPROACHES          66

FIGURE 20         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

VALUE CHAIN ANALYSIS            68

FIGURE 21         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

PORTER’S FIVE FORCE ANALYSIS           69

FIGURE 22         GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–MARCH 2024)    77

FIGURE 23         TOP APPLICANT & OWNER (COMPANIES/INSTITUTIONS) PATENTS

(JANUARY 2014–MARCH 2024)   77

FIGURE 24         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS          84

FIGURE 25         KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS          85

FIGURE 26         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

ECOSYSTEM ANALYSIS 88

FIGURE 27         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

SUPPLY CHAIN ANALYSIS          90

FIGURE 28         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: INVESTMENT & FUNDING SCENARIO, 2018–2023         91

FIGURE 29         NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL

PRODUCTS MARKET SNAPSHOT            163

FIGURE 30         ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL

PRODUCTS MARKET SNAPSHOT          216

FIGURE 31         OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET        287

FIGURE 32         REVENUE ANALYSIS FOR KEY PLAYERS IN GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET (2019–2023)              288

FIGURE 33         MARKET SHARE ANALYSIS OF KEY PLAYERS IN GASTROENTEROLOGY/ GASTROINTESTINAL PRODUCTS MARKET (2023)              289

FIGURE 34         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023           292

FIGURE 35         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY FOOTPRINT          293

FIGURE 36         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023    297

FIGURE 37         GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:

BRAND/PRODUCT COMPARATIVE ANALYSIS    304

FIGURE 38         EV/EBITDA OF KEY VENDORS   304

FIGURE 39         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS          305

FIGURE 40         OLYMPUS CORPORATION: COMPANY SNAPSHOT (2023)              307

FIGURE 41         BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)   315

FIGURE 42         MEDTRONIC PLC: COMPANY SNAPSHOT (2023)             321

FIGURE 43         STRYKER CORPORATION: COMPANY SNAPSHOT (2023)              326

FIGURE 44         FUJIFILM CORPORATION: COMPANY SNAPSHOT (2023)              335

FIGURE 45         CONMED CORPORATION: COMPANY SNAPSHOT (2023)              340

FIGURE 46         JOHNSON & JOHNSON: COMPANY SNAPSHOT (2023)    343

FIGURE 47         MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023)              346

FIGURE 48         STERIS PLC: COMPANY SNAPSHOT (2023)          350

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• コンクリートシーラー市場 – 2030年までの世界予測 2025-04-21
• 自動車用ヒートシールド市場 – 2032年までの世界予測 2025-04-21
• XEVアフターマーケットの進化に関する競争力情報 – 2035年までの世界予測 2025-04-17
• アプリケーションライフサイクル管理市場 – 2029年までの世界予測 2025-04-17
• ヒンダードアミン光安定剤（HALS）市場 – 2030年までの世界予測 2025-04-17

MarketsandMarkets  出版レポート一覧